跳至主要内容
临床试验/RBR-5x7ccxp
RBR-5x7ccxp招募中2 期

Evaluation of the effectiveness of Dolutegravir in HTLV-1 infection: a pilot, open, randomized and controlled study.

Fundação Bahiana de Infectologia - FBA0 个研究点开始时间: 2022年2月11日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 0(—)

入选标准

  • Volunteers aged over 18 years, of both genders, have been diagnosed (by Western blot or PCR) with HTLV-1; not present neurological or cognitive deficits that interfere in the performance of any of the proposed activities.

排除标准

  • Subjects with current HIV, HCV (RNA positive) and HBV (HBsAg positive) infection; Active tuberculosis; Corticosteroid use in the last 30 days; End-stage renal disease (hemodialysis); Cancer; Autoimmune diseases; Wheelchair restricted individuals; Subjects who voluntarily request withdrawal from the study; that do not adapt to the proposed protocols.

研究者

发起方
Fundação Bahiana de Infectologia - FBA

相似试验

Evaluation of the effect of an antiretroviral drug... | 临床试验